Latest Breaking News On - Epygen biotech founder - Page 1 : comparemela.com

With an anticipated price point of less than Rs 150 per dose, this will be the first time an Indian company will be able to adopt the highly productive C1-cell protein production platform.

India
Wuhan
Hubei
China
Israel
Debayan-ghosh
European-union-zoonotic-anticipation
Department-of-biotechnology
Preparedness-initiative
Department-of-biotechnology-india
Epygen-biotech
Receptor-binding-domain